Patients with RP‐ILD show elevated levels of IL‐15, IL‐1RA, CXCL10, VCAM‐1 and ferritin, further supporting the role of systemic inflammatory markers in reflecting disease progression and outcomes.34 The gene discussed is CXCL10; the disease is interstitial lung disease.